Photocure ASA: Presentation at the DNB Nordic Heal

Oslo, Norway, December 13, 2017 - Photocure ASA (OSE: PHO) announces today that the company will present at the DNB Nordic Healthcare Conference on 14th of December 2017 in Oslo, Norway. Presenter will be Ambaw Bellete, President, Photocure Inc. and Head, US Cancer Commercial Operations. The slides presented will be available on Photocure's website ( www.photocure.com ) in the investor relations section.

Company contact: Erik Dahl, Chief Financial Officer Tel: +47 450 55 000 Email: ed@photocure.no

About Photocure Photocure, headquartered in Oslo Norway, is a specialty pharmaceutical company focusing on urology. Based on its unique proprietary Photocure Technology® platform, Photocure is committed to developing and commercializing highly selective and minimally invasive solutions to improve health outcomes for patients worldwide. The company is listed on the Oslo Stock Exchange (OSE: PHO). More information about Photocure is available at www.photocure.com , www.hexvix.com , www.cysview.com .

This information is subject to the disclosure requirements pursuant to section 5-12 of the Norwegian Securities Trading Act.